|
|
100 Clearbrook Road
Elmsford, NY 10523 USA
phone:914-460-1600
fax:(914) 460-1660
|
|
| Symbol |
BIOS |
| Exchange |
nasdaq |
| Founded |
1993 |
| Employees |
390 |
|
|
| www.bioscrip.com/
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Delivers pharmacy benefit management and other pharmacy-related healthcare solutions. |
|
| Management |
| Alfred Carfora, Executive Vice President, Mail Service and PBM Division; Dan Colucci, Vice President, PBM; Russ J. Corvese, Vice President, Mail Operations; Richard H. Friedman, Chairman and Chief Executive Officer; Scott W. Friedman, Vice President, Pharmaceutical Relations; Kristin Johnson, Vice President, Marketing; Barry A. Posner,
Executive Vice President, Secretary and General Counsel; Brian J. Reagan, Executive Vice President, Infusion Division; Stanley Rosenbaum,
Executive Vice President, Chief Financial Officer and Treasurer;
Tom Staloch, Chief Technology Officer; John Brewer, Vice President, Community Pharmacy Division |
| |
|
|
|
|
|
|
|
| Keywords |
| Specialty Pharmacy, Pharmacy Benefit Management (PBM), Mail Service Pharmacy, healthcare solutions |
|
|
|
| Description |
|
BioScrip Inc. was formed from the strategic merger of Chronimed Inc. and MIM Corporation, making us one of the nation's largest pharmacy services companies. The merger brings together the strengths of each company to provide the best in payor contracting, physician support, manufacturer services, clinical management, localized specialty distribution and nationwide fulfillment. |
|
| Products / Services |
Through its BioScrip specialty injectable and infusion therapy programs, MIM distributes high-cost pharmaceuticals and provides clinically focused case and disease management programs to Members afflicted with chronic illnesses or genetic impairments. The disease states or conditions for which the Company has such programs include HIV/AIDS, oncology, hemophilia, multiple sclerosis, growth hormone deficiency, Gaucher's disease, rheumatoid arthritis, infertility, respiratory syncytial virus, hepatitis C, Crohn's disease and transplants.
|
|
| Market / Customers |
MIM provides pharmacy benefits and pharmacy products and services to individual enrollees receiving health benefits, principally through health insurers, including managed care organizations and other insurance companies, and, to a lesser extent, labor unions, self-funded employer groups, government agencies and other self-funded plan sponsors, directly or indirectly through third-party administrators. These services are organized under two operating segments, pharmacy benefit management and mail services and specialty pharmacy distribution and clinical management services.
|
|
| Competitors / Substitutes / Alternatives |
AdvancePCS.Compscript Inc.Express Scripts, Inc.
|
|
| Strategy |
MIM delivers innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. Their mission is to be an invaluable and trusted lifetime partner in healthcare. Their vision is to recognize, understand and exceed partners' expectations by providing sound pharmaceutical healthcare solutions, resulting in the cost-effective enhancement of the patient's quality of life.
|
|
| Status |
| MIM has used the third quarter to continue its transition to a focused, Specialty Management and Delivery platform with complementary PBM services, following the loss of the TennCare PBM business. Results include further reallocation of assets, as well as investments in further intensifying our Specialty sales efforts. They have increased their physician detailed sales force to capitalize on regional strength in the Northeast and Midwest. They have also enhanced customer service by consolidating these activities at Columbus facility. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
